As of April 19, 2025, Design Therapeutics (DSGN) has a market cap of $0.20 billion USD. According to our data, Design Therapeutics is ranked No.6991 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.20 B |
-43.13%
|
Dec 31, 2024 | $0.35 B |
132.83%
|
Dec 29, 2023 | $0.15 B |
-74.17%
|
Dec 30, 2022 | $0.58 B |
-52.08%
|
Dec 31, 2021 | $1.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
Market Cap | = | DSGN Stock Price | * | DSGN Shares Outstanding |
= | $3.50 | * | 56.76 M | |
= | $0.20 B |